Azitra (AZTR) Retained Earnings (2022 - 2026)
Azitra (AZTR) reported Retained Earnings of -$72.4 million for Q1 2026, down 19.55% on a YoY basis from -$90.1 million in Q1 2025, and down 5.73% quarter-over-quarter from -$68.5 million in Q4 2025.
Azitra (AZTR) Retained Earnings (2022 - 2026) Analysis & Trends
Azitra has reported Retained Earnings for 5 years, with the latest figure at -$72.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 19.55% year-over-year to -$72.4 million; the trailing twelve-month figure through Mar 2026 stood at -$72.4 million (down 19.55% YoY), and the FY2025 full-year result was -$68.5 million, down 19.03% from the prior year.
- Retained Earnings for Q1 2026 stood at -$72.4 million, down from -$68.5 million in the prior quarter.
- The five-year high for Retained Earnings was -$37.3 million in Q4 2022, with the low at -$72.4 million in Q1 2026.
- Historically, Retained Earnings has averaged -$55.9 million across 5 years, with a median of -$55.2 million in 2024.
- Annual changes were most pronounced in 2023 — Retained Earnings slumped 30.24% — and 2025, when it decreased 17.28%.
- Azitra's Retained Earnings stood at -$37.3 million in 2022, then tumbled by 30.24% to -$48.6 million in 2023, then retreated by 18.46% to -$57.6 million in 2024, then dropped by 19.03% to -$68.5 million in 2025, then dropped by 5.73% to -$72.4 million in 2026.
- The last three Retained Earnings figures came in at -$72.4 million (Q1 2026), -$68.5 million (Q4 2025), and -$66.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -72.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.45 Mn |
| Dec 31, 2025 | -68.52 Mn |
| Sep 30, 2025 | -66.30 Mn |
| Jun 30, 2025 | -63.52 Mn |
| Mar 31, 2025 | -60.60 Mn |
| Dec 31, 2024 | -57.57 Mn |
| Sep 30, 2024 | -55.17 Mn |
| Jun 30, 2024 | -54.16 Mn |
| Mar 31, 2024 | -51.50 Mn |
| Dec 31, 2023 | -48.60 Mn |
| Sep 30, 2023 | -46.14 Mn |
| Jun 30, 2023 | -44.20 Mn |
| Dec 31, 2022 | -37.31 Mn |